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============

Neuropsychiatric symptoms consequent to malaria and anti-malarial agents have been reported in the literature. The psychiatric manifestations of malaria fever may occur in the form of dreamlike states, amnesias, reduced attention and concentration, insomnia, anxiety, depression, mania, confusional psychosis, and delirium.\[[@ref1]\] However, the description as well as the association of malarial fever as an etiology of the neuro-psychiatric syndrome has been doubted since some time. Furthermore, almost every anti-malarial agent, other than the artemisinin derivatives, has been linked with neuropsychiatric manifestations.\[[@ref2][@ref3][@ref4]\] Herein, we report the development of psychiatric symptoms in a child following exposure to anti-malarial drugs.

Case Details {#sec1-2}
============

A 91/2-year-old boy was admitted to psychiatry inpatient with complaints of abnormal behavior and insomnia for 3 days. His medical history revealed that he recently suffered from a fever that was intermittent, high-grade (102°−103°F), and associated with chills and rigors. However, no cough or cold, nausea and vomiting, diarrhea, headache, seizures or rash was reported. In view of flu-like symptoms, he was initially treated with only oral paracetamol. However, despite taking oral paracetamol (500 mg at every 6 − 8 hours), the fever did not remit. Hence, investigations in the form of complete hemogram and peripheral blood film examination, a chest roentgenogram, ultrasonography of the whole abdomen, card test for malaria, dengue, and serology for typhoid were performed. All the investigations were normal, and a diagnosis of pyrexia of unknown reason was entertained. In addition to paracetamol, amoxycillin and clavulanic acid (250 mg/62.5 mg every 8 hours) were prescribed, but despite a 5-day course, the fever did not remit. Thereafter, he was treated as inpatient and empirically treated with intravenous artesunate at a dosage of 2.4 mg/day for the next 3 days, and his fever subsided. Following this, he was prescribed oral chloroquine at dosages of 300 mg stat followed by 150 mg after 6 hours and then 150 mg/day for the next 2 days. However, one day after the completion of anti-malarial therapy, a new set of symptoms appeared. The child could not sleep properly for the next 3 days. He also complained of irritation in his eyes due to impaction of hair/eyelash, though his parents did not find it. Consequent to repeated rubbing, he developed redness and excessive lacrimation in eyes. He also voiced that hairs grew from his nails and that he could see them and this led to significant distress. Additionally, he reported seeing ants crawling over his body which others could not see. Along with this, he heard voices of his relatives in clear consciousness when they were not around and bore the characteristics of auditory hallucinations. He remained conscious, though parents reported certain instances when he mis-recognized them. Sensory symptoms in the form of increased sensitivity to sound, light, and touch were also reported. Certain psycho-social stressors could be elicited in the form of an authoritarian style of parenting by father and very permissive parenting by mother. At the time of admission, he was afebrile, weighed 33 kg, and had a body mass index of 16.41 Kg/m^2^. His physical examination including detailed neurological examination was normal. His mental state examination revealed increased psychomotor activity, increased speech output, irritable mood, normal cognitive functions, and comprehension. He reported auditory, visual, and tactile hallucinations with preserved insight. He scored 29 on mini-mental state examination which ruled out delirium. Differential diagnosis of malaria, focal encephalitis, pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections was ruled out by physical examination and investigations \[[Table 1](#T1){ref-type="table"}\]. In view of this and screening on MINI-KID 6.0,\[[@ref5]\] a DSM-5 diagnosis of medication-induced psychotic disorder (due to chloroquine) was kept, and he was started on olanzapine 5 mg/d along with clonazepam 0.5 mg at bedtime. The dose of olanzapine was increased to 10 mg/day in a week in view of minimal response. All the symptoms subsided within the next 3 days, and he was discharged. The child has maintained in remission after a month of discharge.

###### 

Investigation results in an index patient

  Investigation                         Result
  ------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------
  Complete hemogram                     Hb-12.8g/dl; TLC-4510/cmm, DLC-N30L57M10E1; Platelets count: 5.5 lac/cmm
  Peripheral blood examination          Normocytic normochromic RBCs, platelets raised on smear, and no hemoparasites
  Liver function test                   SGPT/SGOT=23/17 U/L; Total bilirubin 0.74mg/dl, direct bilirubin: 0.16mg/dl, total proteins: 7.35g/dl, albumin 4.39g/dl, ALP: 250U/L
  Kidney function test                  Urea: 20mg/dl, Creatininge: 0.73mg/dl
  Fasting blood sugar                   80 mg/dL
  Blood culture                         Sterile
  Typhoid IgG/IgM rapid card test       Non-reactive
  Malaria antigen rapid card test       Negative
  Serum sodium/Potassium/Chlorides      138/4.76/103 mmol/L
  Serum calcium                         10 mg/dl
  Throat swab                           No growth was observed on aerobic incubation
  Widal test                            Titers for Salmonella Typhi O and H and Paratyphi AH antigen was \<1:20
  Dengue IgM/IgG by rapid card test     Negative
  Anti-streptolysin O antibody titres   Negative
  Serum Vitamin B 12 level              298 pg/mL
  Serum ceruloplasmin                   28 mg/dL
  Thyroid panel                         Free T3/T4-2.38 pg/mL, 1.33 ng/dL; TSH: 1.13mIU/L
  Electrocardiogram                     Normal
  Electroencephalography                Normal
  Ophthalmological examination          Normal
  Magnetic resonance imaging of brain   Normal

Discussion {#sec1-3}
==========

The World Health Organization (WHO) recommends artemisinin-based combination therapies for the treatment of uncomplicated malaria.\[[@ref6]\] A typical regimen includes once daily dose of artemisinin for 3 days followed by an oral anti-malarial drug. Artesunate has an extremely short half-life (0.5 − 3 hours), and has minimal risk of neuropsychiatric adverse effects. Although high dosages of artemisinin derivatives are associated with neurotoxicity in animal models, evidence is scarce for humans.\[[@ref2][@ref3]\] Only, one case report of induction of mania consequent to arteether treatment in a young child is available.\[[@ref7]\] On the other hand, chloroquine has a low safety margin, it tends to accumulate in the body, and has a long plasma half-life. Therefore, the neuropsychiatric adverse effects consequent to chloroquine may even develop when prescribed in standard doses. The proposed neuro-toxicity is akin to methamphetamine (i.e. due to an excess of dopamine) and fluoroquinolones antibiotics (leading to N-methyl-d-aspartate excitotoxicity and gamma-aminobutyric acid inhibition).\[[@ref8]\] A total of 13 cases of chloroquine-induced psychosis in children have been reported. Biswas *et al*. (2014)\[[@ref9]\] had differentiated psychosis following chloroquine exposure (PFC) from equal number of age-matched patients with brief psychotic disorders (BPD). It was observed that the PFC group had an early onset of psychosis, comprised of mixed affective psychosis, was more restless, irritable, agitated, and had more disturbed thought content, orientation, while insight was better than the BPD group. Further, visual hallucination and derealization were also frequently observed in the PFC group.

In the index case, psychosis was precipitated after the remission of fever, was unlikely to be due to malaria (as tests for it were negative), occurred within a week of initiating anti-malarial therapy (artesunate and chloroquine), with prominent visual hallucinations, sensory symptoms, and historical evidence of disorientation. As all the medications were prescribed in right dosages, and according to WHO guidelines, and that artesunate is rarely shown to lead to neuropsychiatric adverse effects, so the adverse side effect of psychosis possibly occurred consequent to chloroquine (Naranjo Algorithm score = 4).

To conclude, the primary care physicians, pediatricians, and psychiatrists must remain aware of the severe psychiatric side effects of a commonly prescribed anti-malarial drug.
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